age float64 18 102 | sex stringclasses 2
values | hospdead int64 0 1 | slos int64 3 343 | dzgroup stringclasses 8
values | dzclass stringclasses 4
values | num.co int64 0 9 | edu float64 0 31 ⌀ | income stringclasses 4
values | scoma float64 0 100 ⌀ | charges float64 1.17k 1.44M ⌀ | totcst float64 0 633k ⌀ | totmcst float64 -102.72 711k ⌀ | avtisst float64 1 83 ⌀ | race stringclasses 5
values | sps float64 0.2 99.2 ⌀ | aps float64 0 143 ⌀ | surv2m float64 0 0.97 ⌀ | surv6m float64 0 0.95 ⌀ | hday int64 1 148 | diabetes int64 0 1 | dementia int64 0 1 | ca stringclasses 3
values | prg2m float64 0 1 ⌀ | prg6m float64 0 1 ⌀ | dnr stringclasses 3
values | dnrday float64 -88 285 ⌀ | meanbp float64 0 195 ⌀ | wblc float64 0 200 ⌀ | hrt float64 0 300 ⌀ | resp float64 0 90 ⌀ | temp float64 31.7 41.7 ⌀ | pafi float64 12 890 ⌀ | alb float64 0.4 29 ⌀ | bili float64 0.1 63 ⌀ | crea float64 0.1 21.5 ⌀ | sod float64 110 181 ⌀ | ph float64 6.83 7.77 ⌀ | glucose float64 0 1.09k ⌀ | bun float64 1 300 ⌀ | urine float64 0 9k ⌀ | adlp float64 0 7 ⌀ | adls float64 0 7 ⌀ | sfdm2 stringclasses 5
values | adlsc float64 0 7.07 | event_times int64 3 2.03k | event_indicators int64 0 1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
76.67096 | male | 0 | 13 | CHF | COPD/CHF/Cirrhosis | 3 | 16 | >$50k | 0 | 30,798 | 17,669.5 | 16,483.1094 | 29 | white | 19.699219 | 27 | 0.827881 | 0.719971 | 1 | 0 | 0 | no | 0.2 | 0.1 | no dnr | 13 | 62 | 11.099609 | 110 | 42 | 39.29688 | 187.5 | 3 | 0.399963 | 2.899902 | 130 | 7.379883 | 234 | 64 | 1,190 | 0 | 0 | no(M2 and SIP pres) | 0 | 386 | 0 |
77.31396 | male | 0 | 16 | MOSF w/Malig | ARF/MOSF | 1 | 10 | under $11k | 0 | 58,339 | 35,670.3438 | 28,468.2969 | 33 | white | 49.59375 | 84 | 0.007 | 0.001 | 6 | 0 | 0 | metastatic | 0.3 | 0.1 | no dnr | 16 | 131 | 11.898438 | 160 | 27 | 39 | 222 | null | 0.5 | 1.199951 | 147 | 7.469727 | 127 | 26 | 1,239 | 5 | 6 | no(M2 and SIP pres) | 6 | 119 | 1 |
47.41098 | male | 0 | 4 | MOSF w/Malig | ARF/MOSF | 1 | 16 | >$50k | 0 | 19,594 | null | null | 41 | white | 34.5 | 67 | 0.463989 | 0.344971 | 1 | 0 | 0 | yes | 0.3 | 0.15 | no dnr | 4 | 55 | 3.5 | 150 | 22 | 39.39844 | 135.6875 | 2.399902 | 2.799805 | 1.199951 | 139 | 7.389648 | 106 | 17 | 4,420 | null | null | null | 1.923584 | 183 | 1 |
44.25998 | male | 0 | 44 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | null | 0 | 183,799 | null | null | 26.5 | white | 22.296875 | 18 | 0.849976 | 0.79895 | 8 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 44 | 73 | 14.398438 | 70 | 6 | 38.59375 | 334 | null | null | 1 | 144 | 7.459961 | 126 | 16 | 1,715 | null | null | no(M2 and SIP pres) | 2.308106 | 387 | 0 |
29.517 | male | 1 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 19 | under $11k | 0 | 72,789 | null | null | 47 | white | 37.195313 | 50 | 0.687988 | 0.594971 | 4 | 0 | 0 | no | 0.3 | 0.2 | dnr after sadm | 5 | 97 | 5.699219 | 100 | 20 | 38.89844 | 195.21875 | null | null | 1.599854 | 138 | 7.5 | 137 | 22 | null | null | 0 | <2 mo. follow-up | 0 | 9 | 1 |
41.90799 | male | 1 | 5 | Cirrhosis | COPD/CHF/Cirrhosis | 5 | 12 | $25-$50k | 0 | 23,213 | null | null | 51 | white | 40.5 | 52 | 0.487 | 0.284973 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 5 | 80 | 10.298828 | 70 | 25 | 36.69531 | 96.65625 | 4.699219 | 0.399963 | 1.799805 | 139 | 7.399414 | 145 | 31 | 2,620 | null | 0 | <2 mo. follow-up | 0 | 5 | 1 |
72.56897 | female | 0 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 9 | 12,717 | 6,984.9648 | 6,486.97656 | 17 | white | 20.898438 | 25 | 0.803955 | 0.738892 | 1 | 0 | 1 | no | 0.5 | 0.3 | dnr after sadm | 1 | 72 | 7.299805 | 50 | 28 | 35.29688 | 508 | 3.399902 | 1.599854 | 0.899902 | 141 | 7.459961 | 160 | 28 | 1,420 | null | null | adl>=4 (>=5 if sur) | 4.986328 | 384 | 0 |
48.01898 | male | 0 | 5 | Lung Cancer | Cancer | 3 | 12 | $25-$50k | 0 | 23,905 | 12,403.8438 | 3,591.10938 | 14 | white | 17.199219 | 14 | 0.741943 | 0.477966 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 69 | 12.798828 | 80 | 24 | 39.09375 | 506.625 | 3.199707 | 0.799927 | 2 | 144 | 7.509766 | 245 | 47 | 3,110 | 0 | 0 | no(M2 and SIP pres) | 0 | 116 | 1 |
55.633 | male | 0 | 4 | Lung Cancer | Cancer | 2 | 12 | $25-$50k | 0 | 19,481 | null | null | 13 | white | 15.599609 | 10 | 0.754883 | 0.498962 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 116 | 6.199219 | 69 | 22 | 38.19531 | 376.625 | 5.5 | null | 1.099854 | 141 | 6.90918 | 106 | 6 | 8,175 | 0 | null | no(M2 and SIP pres) | 0.494751 | 384 | 0 |
43.20297 | male | 0 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | $11-$25k | 0 | 12,806 | 8,430.7344 | 7,213.02734 | 28 | white | 18.5 | 16 | 0.91394 | 0.882935 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 4 | 73 | 5 | 80 | 16 | 36.79688 | null | 4.599609 | 0.899902 | 0.899902 | 140 | null | 111 | 14 | 1,100 | 0 | null | null | 0.494751 | 383 | 0 |
78.00098 | female | 1 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 56,931 | null | null | 27 | white | 27.5 | 30 | 0.638916 | 0.537964 | 5 | 0 | 0 | no | 0.5 | 0.25 | dnr after sadm | 7 | 103 | 7 | 80 | 30 | 38.89844 | 128.3125 | 3.699707 | null | 0.799927 | 137 | 7.319336 | 98 | 9 | 2,400 | null | 0 | <2 mo. follow-up | 0 | 14 | 1 |
77.61298 | male | 0 | 11 | COPD | COPD/CHF/Cirrhosis | 4 | 8 | under $11k | 0 | 26,894 | 17,784.5312 | 16,116.2969 | 18 | black | 15.5 | 10 | 0.81897 | 0.705933 | 1 | 0 | 0 | yes | 0.9 | 0.8 | no dnr | 11 | 51 | 39.398438 | 80 | 20 | 37 | 121.65625 | null | null | 1.699951 | 144 | 7.479492 | 96 | 50 | 700 | 0 | 0 | no(M2 and SIP pres) | 0 | 379 | 0 |
69.24799 | female | 1 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 0 | 19,191 | 13,670.2812 | 11,447.1875 | 24 | white | 22.199219 | 23 | 0.817993 | 0.755981 | 1 | 0 | 0 | no | 0.01 | 0.01 | dnr after sadm | 5 | 70 | 12.898438 | 114 | 28 | 38.09375 | 304.75 | 3.099609 | 0.899902 | 0.699951 | 131 | 7.349609 | 189 | 13 | null | null | null | <2 mo. follow-up | 2.12793 | 5 | 1 |
59.44699 | male | 0 | 5 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | $25-$50k | 0 | 4,928 | null | null | 6 | white | 22.5 | 18 | 0.753906 | 0.611938 | 1 | 1 | 0 | no | 0.9 | 0.75 | no dnr | 5 | 100 | null | 70 | 20 | 36.69531 | null | null | null | 0.699951 | 139 | null | 144 | 7 | null | 0 | 0 | no(M2 and SIP pres) | 0 | 334 | 1 |
86.13599 | male | 0 | 26 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 59,443 | 42,862.625 | 34,750.9375 | 23.75 | white | 40.796875 | 54 | 0.282959 | 0.173981 | 1 | 0 | 0 | no | 0.4 | 0.3 | no dnr | 26 | 60 | 7.899414 | 130 | 26 | 38 | 353.3125 | null | null | 6.199219 | 134 | 7.389648 | 80 | 43 | 0 | 0 | 0 | <2 mo. follow-up | 0 | 40 | 1 |
71.56195 | female | 1 | 11 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | null | 41 | 31,438 | 23,215.6094 | 18,722.25 | 32.5 | white | 25.5 | 49 | 0.598999 | 0.408997 | 1 | 0 | 0 | no | 0.5 | 0.7 | dnr after sadm | 5 | 107 | 9.699219 | 70 | 20 | 36.09375 | 238.09375 | null | null | 6.099609 | 142 | 7.349609 | 124 | 68 | null | null | 6 | <2 mo. follow-up | 6 | 11 | 1 |
81.91895 | male | 1 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 0 | 12,394 | 8,817.6406 | 6,931.17969 | 27 | white | 43.695313 | 68 | 0.154999 | 0.074997 | 1 | 1 | 0 | yes | 0.1 | 0.01 | dnr before sadm | -1 | 70 | 10.898438 | 92 | 50 | 37.09375 | null | null | null | 0.599976 | 136 | null | 81 | 6 | 700 | null | null | <2 mo. follow-up | 3.209473 | 6 | 1 |
86.80896 | female | 1 | 50 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | $11-$25k | 0 | 222,569 | null | null | 35.5 | white | 25.5 | 52 | 0.691895 | 0.600952 | 1 | 0 | 0 | no | 0.8 | 0.6 | dnr after sadm | 39 | 80 | 4.599609 | 80 | 20 | 36.09375 | null | 3.799805 | 0.599976 | 1.5 | 138 | null | 83 | 20 | 1 | 0 | 0 | <2 mo. follow-up | 0 | 50 | 1 |
52.76398 | male | 1 | 9 | MOSF w/Malig | ARF/MOSF | 1 | 10 | null | 0 | 38,836 | 28,903.2031 | 22,790.8125 | 45 | white | 30 | 54 | 0.578979 | 0.468994 | 1 | 0 | 0 | yes | 0.05 | 0.01 | dnr after sadm | 4 | 106 | 10.099609 | 62 | 54 | 38.19531 | 217.5 | 1 | null | 1.699951 | 139 | 7.389648 | 95 | 38 | 500 | null | 0 | <2 mo. follow-up | 0 | 9 | 1 |
77.42896 | male | 0 | 8 | CHF | COPD/CHF/Cirrhosis | 5 | 9 | under $11k | 0 | 9,491 | 5,027 | 4,679.55859 | 7.5 | white | 16.699219 | 29 | 0.860962 | 0.769897 | 1 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 8 | 67 | 21.398438 | 60 | 20 | 36.09375 | 319 | null | 0.199982 | 0.699951 | 142 | 7.479492 | 498 | 32 | 2,100 | 1 | 0 | no(M2 and SIP pres) | 0 | 179 | 1 |
74.72998 | female | 1 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 9 | 24,127 | 21,646.7188 | 16,400.8594 | 32 | white | 31.699219 | 76 | 0.577881 | 0.467957 | 1 | 1 | 0 | no | 0 | 0 | dnr after sadm | 2 | 53 | 5.699219 | 60 | 20 | 35.59375 | 266.625 | 3.699707 | 1.699951 | 1.799805 | 144 | 7.449219 | 166 | 92 | null | null | null | <2 mo. follow-up | 3.767578 | 9 | 1 |
84.745 | male | 0 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | null | 0 | 32,357 | 19,647.4688 | 19,541.6406 | 18.666656 | white | 25.296875 | 29 | 0.705933 | 0.61792 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 18 | 122 | 13.298828 | 157 | 38 | 36.09375 | 285 | null | 0.699951 | 0.799927 | 137 | 7.299805 | 209 | 23 | 750 | 0 | 1 | no(M2 and SIP pres) | 1 | 107 | 1 |
88.19397 | female | 0 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $25-$50k | 9 | 19,104 | 13,220.2812 | 11,556.3984 | 11 | white | 25 | 45 | 0.660889 | 0.562988 | 1 | 0 | 1 | no | 0.8 | 0.7 | dnr after sadm | 3 | 107 | 8.5 | 68 | 24 | 38.5 | 275 | 3.599609 | 0.699951 | 1 | 137 | 7.359375 | 284 | 16 | 1,285 | null | 3 | no(M2 and SIP pres) | 3 | 356 | 0 |
67.02295 | female | 0 | 53 | MOSF w/Malig | ARF/MOSF | 0 | 13 | null | 9 | 159,022 | null | null | 19.75 | white | 30.5 | 42 | 0.356995 | 0.23999 | 45 | 0 | 0 | yes | 0.7 | 0.3 | dnr after sadm | 20 | 60 | 14.599609 | 61 | 8 | 38.29688 | 80 | null | null | 1.799805 | 146 | 7.349609 | 121 | 26 | 3,765 | 2 | 1 | SIP>=30 | 1 | 104 | 1 |
47.45798 | male | 0 | 7 | CHF | COPD/CHF/Cirrhosis | 6 | 10 | under $11k | 0 | 17,973 | 10,558.2734 | 9,141.5 | 7.5 | white | 23.699219 | 38 | 0.872925 | 0.78894 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 7 | 79 | 24.597656 | 71 | 18 | 35.59375 | 362 | 2.099609 | 6.599609 | 1.5 | 152 | 7.419922 | 561 | 45 | 3,585 | 0 | 0 | no(M2 and SIP pres) | 0 | 238 | 1 |
76.87097 | male | 0 | 6 | CHF | COPD/CHF/Cirrhosis | 3 | 18 | $11-$25k | 0 | 5,444 | 3,222.0918 | 3,093.62891 | 7 | white | 21.597656 | 26 | 0.80188 | 0.680908 | 1 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 6 | 113 | 30.699219 | 80 | 16 | 36.19531 | 170 | null | 29.097656 | 7.199219 | 136 | 7.339844 | 85 | 118 | 185 | 1 | null | no(M2 and SIP pres) | 1.166748 | 352 | 0 |
73.92694 | female | 0 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | $11-$25k | 9 | 21,820 | 13,192.5547 | 14,935.5547 | 16.5 | hispanic | 15.699219 | 18 | 0.862915 | 0.815918 | 1 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 8 | 103 | 9.298828 | 60 | 20 | 37.79688 | null | null | null | 1.699951 | 141 | null | 104 | 23 | 5,200 | 0 | 3 | no(M2 and SIP pres) | 3 | 351 | 0 |
62.89099 | female | 0 | 4 | COPD | COPD/CHF/Cirrhosis | 6 | 12 | under $11k | 0 | 4,700 | 2,471.3027 | 2,245.6582 | 6 | white | 14 | 13 | 0.899902 | 0.831909 | 1 | 1 | 0 | yes | 0.9 | 0.5 | dnr before sadm | -1 | 43 | 4.899414 | 64 | 26 | 37.69531 | 176.65625 | null | null | 1.799805 | 135 | 7.439453 | 76 | 33 | 525 | 6 | null | SIP>=30 | 4.527344 | 348 | 0 |
83.72296 | male | 0 | 8 | CHF | COPD/CHF/Cirrhosis | 5 | null | under $11k | 0 | 11,448 | 5,841.5977 | 4,862.32812 | 8.5 | white | 18.898438 | 26 | 0.768921 | 0.632935 | 1 | 0 | 0 | yes | 0.95 | 0.5 | no dnr | 8 | 80 | 9.398438 | 50 | 20 | 36.09375 | null | null | null | 1.5 | 142 | null | 76 | 31 | 1,450 | 0 | 0 | null | 0 | 347 | 0 |
73.15796 | male | 1 | 17 | Lung Cancer | Cancer | 1 | 8 | $11-$25k | 9 | 30,549 | 15,945.3047 | 15,568.4141 | 13.333328 | white | 20.097656 | 9 | 0.578979 | 0.258972 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | dnr after sadm | 14 | 100 | 17.199219 | 130 | 40 | 35.89844 | 131.65625 | 2.099609 | null | 0.799927 | 137 | 7.5 | 178 | 22 | 700 | 2 | 1 | <2 mo. follow-up | 1 | 17 | 1 |
97.59595 | male | 0 | 5 | CHF | COPD/CHF/Cirrhosis | 2 | 20 | >$50k | 0 | 6,900 | 3,685.7031 | 3,522.57812 | 11 | white | 15.199219 | 26 | 0.767944 | 0.630981 | 1 | 0 | 0 | yes | 0.5 | 0.3 | dnr after sadm | 1 | 130 | 4.399414 | 80 | 20 | 37.79688 | null | null | null | 5.199219 | 143 | null | 118 | 50 | 950 | null | null | adl>=4 (>=5 if sur) | 4.043945 | 247 | 1 |
84.67596 | female | 0 | 29 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $11-$25k | 0 | 123,202 | null | null | 26 | white | 21.796875 | 36 | 0.75293 | 0.674927 | 2 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 29 | 113 | 14.898438 | 80 | 25 | 36.09375 | 138.3125 | null | null | 3.799805 | 145 | 7.439453 | 117 | 72 | 950 | 2 | 0 | no(M2 and SIP pres) | 0 | 344 | 0 |
81.06995 | female | 1 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | $25-$50k | 9 | 29,290.906 | 16,614.9375 | null | 40 | white | 31.398438 | 61 | 0.349976 | 0.232971 | 13 | 0 | 0 | yes | 0.05 | 0.000125 | dnr before sadm | 0 | 115 | 24 | 142 | 36 | 37.69531 | 143.3125 | 2.5 | 0.799927 | 1.5 | 155 | 7.389648 | null | null | null | null | 2 | <2 mo. follow-up | 2 | 5 | 1 |
78.10797 | male | 1 | 15 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | under $11k | 37 | 59,070.875 | 33,565.2812 | null | 34 | black | 26.398438 | 57 | 0.422974 | 0.302979 | 4 | 0 | 0 | yes | 0.5 | 0.25 | dnr after sadm | 14 | 107 | 6.399414 | 118 | 26 | 38.5 | 260 | 1.899902 | 4.699219 | 2 | 139 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 | 15 | 1 |
66.16595 | female | 1 | 35 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 20 | $11-$25k | 0 | 204,219.875 | 112,552.25 | null | 49.5 | black | 25.597656 | 35 | 0.711914 | 0.623901 | 13 | 1 | 0 | no | 0.5 | 0.5 | dnr after sadm | 34 | 117 | 10 | 110 | 8 | 39 | 290 | null | null | 3.5 | 134 | 7.429688 | null | null | null | null | 2 | <2 mo. follow-up | 2 | 35 | 1 |
27.76199 | female | 1 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 44 | 70,693.625 | 40,952.1562 | null | 52 | black | 48.195313 | 88 | 0.246979 | 0.143982 | 1 | 0 | 0 | no | 0.3 | 0.2 | dnr after sadm | 16 | 60 | 13.699219 | 152 | 12 | 35.69531 | 76.65625 | 1.599854 | 13.099609 | 3.599609 | 132 | 7.40918 | null | null | null | null | 0 | <2 mo. follow-up | 0 | 17 | 1 |
71.29095 | male | 0 | 12 | CHF | COPD/CHF/Cirrhosis | 2 | 9 | under $11k | 0 | 15,564.695 | 9,390.3203 | null | 18 | white | 16 | 25 | 0.875 | 0.791992 | 2 | 0 | 0 | no | 0.9 | 0.5 | no dnr | 12 | 80 | 8.199219 | 80 | 22 | 36.5 | 226.65625 | null | null | 1.599854 | 137 | 7.459961 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 | 744 | 1 |
63.67099 | male | 0 | 6 | Lung Cancer | Cancer | 1 | 9 | under $11k | 0 | 5,074.648 | 3,149.7344 | null | 11 | white | 33.398438 | 35 | 0.27594 | 0.040993 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 6 | 87 | 26 | 108 | 36 | 37.69531 | 314.25 | 2.399902 | 0.399963 | 0.799927 | 139 | 7.479492 | null | null | null | 2 | 4 | null | 4 | 70 | 1 |
42.09698 | male | 1 | 9 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 44 | 65,025.031 | 35,397.4062 | null | 62.5 | white | 43.195313 | 92 | 0.007999 | 0.001 | 11 | 0 | 0 | metastatic | 0.1 | 0.001 | no dnr | 9 | 63 | 0.199982 | 145 | 28 | 37.89844 | 242.84375 | 2 | 5.199219 | 4.099609 | 161 | 7.519531 | null | null | null | null | null | <2 mo. follow-up | 2.985352 | 9 | 1 |
66.30499 | female | 1 | 43 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | $11-$25k | 37 | 182,129.875 | 103,131.188 | null | 45 | white | 24 | 37 | 0.688965 | 0.596924 | 1 | 0 | 0 | no | 0.7 | 0.75 | dnr after sadm | 31 | 93 | 18.796875 | 100 | 10 | 38.5 | 203.3125 | 2 | 1 | 3.099609 | 138 | 7.369141 | null | null | null | null | 1 | <2 mo. follow-up | 1 | 43 | 1 |
29.33299 | female | 0 | 20 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | null | 0 | 48,388.219 | 28,524.0625 | null | 35.333313 | white | 24.699219 | 48 | 0.892944 | 0.85498 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 20 | 62 | 27.796875 | 62 | 16 | 38.79688 | 118.45312 | 1.899902 | 3 | 0.899902 | 140 | 7.449219 | null | null | null | null | 0 | null | 0 | 2,026 | 0 |
48.87097 | male | 0 | 14 | Colon Cancer | Cancer | 1 | 17 | >$50k | 0 | 13,197.648 | 7,754.8945 | null | 13.666664 | white | 25.597656 | 15 | 0.710938 | 0.429993 | 1 | 0 | 0 | metastatic | 0.8 | 0.2 | no dnr | 14 | 101 | 5.199219 | 95 | 18 | 38.5 | null | 2.399902 | 0.199982 | 0.899902 | 137 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 | 207 | 1 |
71.81696 | female | 0 | 21 | CHF | COPD/CHF/Cirrhosis | 4 | 10 | null | 0 | 11,220.297 | 8,075.2109 | null | 11 | black | 24.5 | 36 | 0.779907 | 0.648926 | 1 | 0 | 0 | no | 1 | 0.8 | dnr after sadm | 2 | 130 | 5.799805 | 60 | 26 | 35.5 | 509.5 | 2.799805 | 0.5 | 1.5 | 139 | 7.379883 | null | null | null | null | 7 | <2 mo. follow-up | 7 | 24 | 1 |
63.48297 | male | 0 | 6 | Colon Cancer | Cancer | 0 | 18 | >$50k | 0 | 3,371.1 | 2,288.6973 | null | 6 | white | 19 | 9 | 0.790894 | 0.559937 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 6 | 83 | 4.699219 | 72 | 24 | 36.69531 | null | 3 | 0.5 | 0.899902 | 139 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 | 1,162 | 1 |
60.939 | male | 0 | 4 | CHF | COPD/CHF/Cirrhosis | 0 | 7 | $11-$25k | 0 | 4,007.6 | 2,527.5527 | null | 7 | black | 13.599609 | 6 | 0.921997 | 0.868896 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 4 | 97 | 5.599609 | 80 | 20 | 36.59375 | null | null | null | 1 | 139 | null | null | null | null | 1 | 3 | no(M2 and SIP pres) | 3 | 455 | 1 |
74.52399 | female | 0 | 12 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 5,275.547 | 3,996.9512 | null | 7 | white | 13.099609 | 18 | 0.900879 | 0.832886 | 1 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 12 | 87 | 3.899902 | 65 | 20 | 35.89844 | null | 4.099609 | 0.899902 | 1.199951 | 144 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 | 891 | 1 |
50.42599 | male | 0 | 5 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 2,317.148 | 1,679.041 | null | 1 | white | 18.796875 | 19 | 0.851929 | 0.756958 | 1 | 0 | 0 | no | 0.98 | 0.8 | no dnr | 5 | 96 | 5.299805 | 82 | 20 | 37.09375 | null | 2.599609 | 5.399414 | 0.899902 | 133 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 | 1,753 | 1 |
45.91098 | female | 0 | 7 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 3,229.148 | 2,311.6875 | null | 5.5 | white | 16.796875 | 30 | 0.859985 | 0.768921 | 1 | 0 | 0 | yes | 0.98 | 0.9 | no dnr | 7 | 69 | 4.099609 | 60 | 16 | 37.39844 | null | 2.299805 | 2.099609 | 1.399902 | 135 | null | null | null | null | 0 | 5 | no(M2 and SIP pres) | 5 | 85 | 1 |
33.73297 | female | 0 | 32 | CHF | COPD/CHF/Cirrhosis | 0 | 10 | under $11k | 0 | 65,649.062 | 43,195.5 | null | 20.75 | white | 20.097656 | 15 | 0.927979 | 0.876953 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 32 | 77 | 20.398438 | 110 | 16 | 37.09375 | 328 | null | 0.399963 | 0.699951 | 138 | 7.429688 | null | null | null | null | 3 | no(M2 and SIP pres) | 3 | 2,021 | 0 |
46.77899 | female | 1 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | $11-$25k | 94 | 18,037.5 | 9,498.8984 | null | 28 | white | 21.097656 | 13 | 0.608887 | 0.50293 | 2 | 0 | 0 | no | null | null | dnr after sadm | 3 | 85 | 22.398438 | 130 | 14 | 39.09375 | 432.5 | 3.799805 | 0.699951 | 0.899902 | 137 | 7.449219 | null | null | null | null | 1 | <2 mo. follow-up | 1 | 6 | 1 |
49.85098 | male | 1 | 23 | MOSF w/Malig | ARF/MOSF | 1 | 11 | null | 44 | 70,955.75 | 41,781.0625 | null | 33.333313 | white | 27.699219 | 39 | 0.315979 | 0.202972 | 14 | 0 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 8 | 67 | 1.399902 | 112 | 25 | 37.39844 | 300 | 2.099609 | 1.399902 | 0.699951 | 142 | 7.469727 | null | null | null | null | 6 | <2 mo. follow-up | 6 | 23 | 1 |
50.82797 | female | 0 | 6 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | null | under $11k | 0 | 12,101.797 | 7,537.4258 | null | 14 | white | 24.898438 | 32 | 0.716919 | 0.559937 | 6 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 6 | 91 | 10.099609 | 125 | 22 | 36.89844 | null | null | 2.899902 | 1.899902 | 136 | null | null | null | null | 0 | 0 | SIP>=30 | 0 | 2,020 | 0 |
68.01398 | female | 1 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 1 | null | 0 | 68,718.562 | 37,504.25 | null | 45.666657 | other | 28.199219 | 39 | 0.68396 | 0.590942 | 4 | 1 | 0 | no | 0.5 | 0.4 | no dnr | 17 | 90 | 18.296875 | 100 | 10 | 37.29688 | 147.5 | 2.699707 | 0.5 | 3.199707 | 137 | 7.429688 | null | null | null | null | 1 | <2 mo. follow-up | 1 | 17 | 1 |
62.67999 | male | 0 | 10 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 5,012.098 | 3,631.3223 | null | 5.5 | white | 17.097656 | 29 | 0.893921 | 0.822998 | 1 | 0 | 0 | no | 0.75 | 0.5 | no dnr | 10 | 63 | 7 | 100 | 24 | 36.19531 | 319 | 3.799805 | 0.699951 | 1.599854 | 137 | 7.479492 | null | null | null | 0 | 0 | null | 0 | 248 | 1 |
54.543 | male | 0 | 35 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 119,274.125 | 68,801.75 | null | 31 | white | 25 | 45 | 0.827881 | 0.768921 | 1 | 0 | 0 | no | 0.2 | 0.1 | no dnr | 35 | 109 | 16.5 | 118 | 40 | 38.79688 | 176.34375 | 1.399902 | 0.199982 | 0.799927 | 136 | 7.389648 | null | null | null | null | 2 | null | 2 | 472 | 1 |
82.62 | female | 1 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 0 | 123,505.188 | 67,257.9375 | null | 35.5 | white | 36.5 | 55 | 0.303955 | 0.191986 | 27 | 0 | 0 | no | null | null | dnr after sadm | 6 | 73 | 30 | 110 | 11 | 35.89844 | 116.65625 | 2.799805 | 0.799927 | 3.399902 | 151 | 7.319336 | null | null | null | null | 1 | <2 mo. follow-up | 1 | 7 | 1 |
54.55399 | male | 0 | 10 | CHF | COPD/CHF/Cirrhosis | 2 | 14 | $11-$25k | 0 | 14,758.742 | 8,782.7109 | null | 19 | black | 18.296875 | 23 | 0.901978 | 0.835938 | 1 | 0 | 0 | no | null | null | no dnr | 10 | 90 | 7.799805 | 104 | 32 | 36.59375 | null | null | null | 1.099854 | 137 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 | 2,015 | 0 |
48.827 | female | 0 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 9 | 24,232.469 | 14,970.9062 | null | 28 | white | 24.796875 | 40 | 0.825928 | 0.767944 | 1 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 14 | 60 | 16.398438 | 108 | 24 | 37.5 | 368 | 1.699951 | 1.799805 | 2.799805 | 140 | 7.389648 | null | null | null | 1 | 1 | SIP>=30 | 1 | 2,015 | 0 |
42.41498 | male | 1 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 100 | 26,228.594 | 14,142.5312 | null | 54 | white | 56.59375 | 96 | 0 | 0 | 6 | 0 | 0 | no | null | null | dnr after sadm | 4 | 47 | 16.5 | 200 | 34 | 39 | 74 | 2.599609 | 30.5 | 6.199219 | 141 | 7.229492 | null | null | null | null | null | <2 mo. follow-up | 2.881348 | 5 | 1 |
70.01196 | male | 0 | 5 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 2,736.148 | 1,958.3613 | null | 11 | black | 16.5 | 15 | 0.87793 | 0.797974 | 1 | 0 | 0 | no | 1 | 0.8 | no dnr | 5 | 113 | 13.099609 | 70 | 20 | 36.19531 | 252.375 | null | null | 1.099854 | 138 | 7.479492 | null | null | null | null | null | null | 3.185547 | 1,781 | 1 |
60.34497 | female | 0 | 7 | COPD | COPD/CHF/Cirrhosis | 2 | 10 | under $11k | 0 | 5,197.066 | 3,336.3731 | null | 8 | white | 14.199219 | 29 | 0.925903 | 0.873901 | 1 | 0 | 0 | no | 0.95 | 0.8 | no dnr | 7 | 99 | 7.399414 | 90 | 28 | 37.09375 | 194.375 | 4.099609 | 0.5 | 0.799927 | 144 | 7.369141 | null | null | null | 2 | 3 | no(M2 and SIP pres) | 3 | 1,761 | 1 |
55.98898 | female | 0 | 6 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | $11-$25k | 0 | 6,171.199 | 3,968.0488 | null | 10 | white | 19.796875 | 19 | 0.886963 | 0.810913 | 1 | 1 | 0 | no | 1 | 0.99 | no dnr | 6 | 108 | 10.699219 | 126 | 18 | 37.29688 | null | null | null | 1 | 144 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 | 2,015 | 0 |
42.89099 | male | 0 | 4 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 4,847.797 | 2,779.7148 | null | 12 | white | 17.699219 | 19 | 0.92688 | 0.875977 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 4 | 77 | 8.599609 | 94 | 16 | 36.5 | null | null | null | 1.699951 | 139 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 | 1,380 | 1 |
26.407 | female | 1 | 15 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 10 | under $11k | 9 | null | null | null | 33.333313 | black | 44.296875 | 84 | 0.363953 | 0.171997 | 30 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 15 | 52 | 52 | 82 | 25 | 36.89844 | 285.6875 | 2.299805 | 44.09375 | 5 | 139 | 7.389648 | null | null | null | 6 | null | <2 mo. follow-up | 4.527397 | 15 | 1 |
55.13797 | male | 0 | 5 | Lung Cancer | Cancer | 1 | 14 | $25-$50k | 0 | 4,260.598 | 2,585.875 | null | 10 | white | 24.597656 | 18 | 0.55896 | 0.237 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 5 | 73 | 9.798828 | 84 | 12 | 38.5 | null | 2.699707 | 0.199982 | 0.599976 | 139 | null | null | null | null | 0 | 4 | null | 4 | 65 | 1 |
37.65399 | female | 0 | 7 | Colon Cancer | Cancer | 1 | 17 | $25-$50k | 0 | 25,829.297 | 14,263.2422 | null | 14 | other | 14 | 5 | 0.889893 | 0.748901 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 7 | 91 | 4.399414 | 86 | 20 | 37.59375 | null | null | 0.299988 | 0.699951 | 144 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 | 21 | 1 |
64.323 | female | 0 | 8 | CHF | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 3,637.6 | 2,708.7031 | null | 10 | black | 24.597656 | 34 | 0.80896 | 0.690918 | 1 | 1 | 0 | no | 0.75 | 0.6 | no dnr | 8 | 110 | 23.199219 | 100 | 16 | 36.59375 | 270 | null | 0.199982 | 5.199219 | 144 | 7.339844 | null | null | null | 1 | null | null | 1.1669 | 2,013 | 0 |
58.21198 | female | 1 | 3 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | null | null | 100 | 14,696.945 | 8,260.25 | null | 32 | white | 59 | 104 | 0 | 0 | 1 | 1 | 0 | no | null | null | dnr after sadm | 2 | 37 | 34.296875 | 35 | 12 | 35.79688 | 261 | 2.399902 | 8.798828 | 3 | 122 | 7.269531 | null | null | null | null | null | <2 mo. follow-up | 3.397949 | 3 | 1 |
71.31799 | male | 1 | 14 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 25,847.641 | 15,369.0859 | null | 24 | black | 18.597656 | 25 | 0.850952 | 0.754883 | 1 | 0 | 0 | no | 1 | 0.8 | no dnr | 14 | 102 | 11.298828 | 88 | 28 | 36.5 | 229.15625 | null | null | 0.799927 | 146 | 7.339844 | null | null | null | null | null | <2 mo. follow-up | 3.169922 | 14 | 1 |
69.79095 | male | 0 | 35 | CHF | COPD/CHF/Cirrhosis | 5 | null | null | 0 | 50,310.688 | 30,847.0469 | null | 16 | white | 18.296875 | 28 | 0.865967 | 0.778931 | 1 | 0 | 0 | no | null | 0.5 | no dnr | 35 | 63 | null | 70 | 20 | 35.09375 | 566.625 | null | null | 1.299805 | 137 | 7.399414 | null | null | null | null | null | null | 3.318848 | 296 | 1 |
69.92694 | female | 1 | 21 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 9 | under $11k | 37 | 82,018.938 | 47,612.4375 | null | 46 | white | 32.09375 | 57 | 0.461975 | 0.342957 | 1 | 1 | 0 | no | 0.1 | 0.001 | no dnr | 21 | 113 | 19.597656 | 65 | 27 | 35 | 147.5 | 1.699951 | 0.199982 | 2.899902 | 135 | 7.40918 | null | null | null | null | 1 | <2 mo. follow-up | 1 | 21 | 1 |
44.35599 | female | 0 | 136 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 26 | 336,191.75 | 191,845.5 | null | 32.75 | white | 31.097656 | 47 | 0.587891 | 0.478943 | 28 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 136 | 130 | 20.398438 | 100 | 10 | 36.89844 | 170 | 3.899902 | 12.599609 | 1.299805 | 138 | 7.479492 | null | null | null | 2 | 0 | SIP>=30 | 0 | 2,009 | 0 |
46.83899 | male | 0 | 6 | CHF | COPD/CHF/Cirrhosis | 2 | 11 | $11-$25k | 0 | 4,346.148 | 3,380.3809 | null | 3 | white | 17.199219 | 19 | 0.92395 | 0.870972 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 71 | 6 | 68 | 24 | 36.59375 | 357.125 | null | 1.099854 | 1.799805 | 141 | 7.419922 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 | 2,009 | 0 |
65.28998 | female | 0 | 29 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 44 | 115,224.25 | 67,811.125 | null | 18 | black | 23.898438 | 20 | 0.563965 | 0.451965 | 26 | 0 | 0 | no | null | null | no dnr | 29 | 83 | 22.699219 | 110 | 26 | 38 | 463.3125 | 3.399902 | null | 0.599976 | 152 | 7.479492 | null | null | null | null | null | null | 3.089356 | 2,008 | 0 |
69.05396 | male | 0 | 5 | CHF | COPD/CHF/Cirrhosis | 1 | 11 | $11-$25k | 0 | null | null | null | 7 | white | 18.796875 | 25 | 0.862915 | 0.772949 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 5 | 73 | 7 | 68 | 20 | 35.39844 | null | null | null | 1.5 | 143 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 | 132 | 1 |
18.946 | male | 1 | 12 | MOSF w/Malig | ARF/MOSF | 2 | 9 | null | 9 | 61,863.156 | 34,996.3438 | null | 43 | black | 36 | 63 | 0.339966 | 0.223999 | 7 | 0 | 0 | yes | 0.4 | 0.4 | dnr after sadm | 9 | 110 | 0.099991 | 110 | 29 | 37.79688 | 137.125 | 1.599854 | 1.399902 | 0.5 | 146 | 7.40918 | null | null | null | null | 3 | <2 mo. follow-up | 3 | 12 | 1 |
23.573 | female | 1 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | null | 0 | 63,657.625 | 36,136.1562 | null | 45 | white | 36.59375 | 56 | 0.68396 | 0.590942 | 23 | 0 | 0 | no | 0 | 0 | no dnr | 7 | 110 | 0.199982 | 184 | 26 | 39.29688 | 128.875 | null | 0.199982 | 0.799927 | 134 | 7.389648 | null | null | null | null | 0 | <2 mo. follow-up | 0 | 7 | 1 |
71.07996 | male | 0 | 14 | CHF | COPD/CHF/Cirrhosis | 6 | 16 | under $11k | 0 | 10,907.797 | 8,287.3438 | null | 13.666664 | hispanic | 18 | 35 | 0.86499 | 0.775879 | 1 | 1 | 0 | no | 0.5 | 0.25 | dnr after sadm | 3 | 63 | 5.099609 | 89 | 16 | 37.29688 | 223.78125 | null | 1.199951 | 1.099854 | 128 | 7.509766 | null | null | null | 6 | 4 | SIP>=30 | 4 | 487 | 1 |
73.40198 | male | 1 | 11 | MOSF w/Malig | ARF/MOSF | 2 | 11 | $11-$25k | 26 | 80,833.062 | 46,143.8125 | null | 43 | white | 43.695313 | 86 | 0.019997 | 0.004 | 30 | 0 | 0 | yes | 0.05 | 0.000125 | dnr after sadm | 10 | 137 | 1.799805 | 140 | 30 | 39.19531 | 146.65625 | 1.299805 | 13.199219 | 2.299805 | 139 | 7.399414 | null | null | null | null | 1 | <2 mo. follow-up | 1 | 11 | 1 |
61.599 | female | 1 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 100 | 20,699.797 | 13,587.9766 | null | 43 | white | 39.398438 | 59 | 0.052994 | 0.016998 | 1 | 0 | 0 | no | 0.3 | 0.3 | dnr after sadm | 3 | 48 | 11.099609 | 118 | 12 | 36.69531 | 227.5 | 2.299805 | 5.799805 | 4.099609 | 138 | 7.359375 | null | null | null | null | null | <2 mo. follow-up | 3.058106 | 4 | 1 |
39.31 | male | 1 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 13 | null | 0 | 32,710.188 | 20,681.2969 | null | 17.5 | black | 31.699219 | 44 | 0.728882 | 0.644897 | 8 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 1 | 94 | 21.699219 | 120 | 24 | 37.29688 | 363.3125 | null | 8.798828 | 1.899902 | 132 | 7.359375 | null | null | null | 2 | 3 | <2 mo. follow-up | 3 | 11 | 1 |
62.26398 | male | 0 | 5 | Lung Cancer | Cancer | 2 | 13 | $25-$50k | 0 | 4,991.348 | 3,246.8242 | null | 15 | white | 21 | 17 | 0.62793 | 0.315979 | 1 | 0 | 0 | metastatic | 1 | 0.6 | no dnr | 5 | 127 | 5.399414 | 115 | 20 | 36 | null | null | null | 0.799927 | 135 | null | null | null | null | 0 | 0 | null | 0 | 63 | 1 |
78.93799 | female | 0 | 12 | Lung Cancer | Cancer | 2 | null | null | 0 | 11,457.445 | 8,526.6406 | null | 10.5 | white | 16.199219 | 24 | 0.691895 | 0.40094 | 1 | 0 | 0 | metastatic | 0.75 | 0.5 | no dnr | 12 | 87 | 7.199219 | 68 | 32 | 39 | null | null | null | 1.099854 | 133 | null | null | null | null | null | null | null | 3.381836 | 435 | 1 |
67.745 | female | 0 | 7 | Colon Cancer | Cancer | 3 | 12 | null | 0 | 7,447.699 | 5,835.6016 | null | 12 | white | 34.09375 | 35 | 0.43396 | 0.125977 | 1 | 0 | 0 | metastatic | 0.8 | 0.1 | no dnr | 7 | 110 | 6.5 | 72 | 16 | 36.79688 | null | 1.899902 | null | 1.699951 | 137 | null | null | null | null | null | 2 | <2 mo. follow-up | 2 | 23 | 1 |
59.45499 | male | 0 | 11 | CHF | COPD/CHF/Cirrhosis | 4 | 10 | under $11k | 0 | 14,134.297 | 10,915.0625 | null | 12.5 | white | 33.09375 | 56 | 0.613892 | 0.426941 | 7 | 1 | 0 | no | 0.8 | 0.6 | no dnr | 11 | 58 | 12.699219 | 120 | 28 | 37.29688 | null | null | null | 2.199707 | 124 | null | null | null | null | 1 | 2 | <2 mo. follow-up | 2 | 25 | 1 |
72.91998 | male | 1 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | under $11k | 0 | null | null | null | 43.5 | white | 32.195313 | 51 | 0.61499 | 0.508911 | 1 | 0 | 0 | no | 0.2 | 0.2 | dnr after sadm | 3 | 132 | 16.597656 | 116 | 25 | 38.5 | 98.875 | null | 0.5 | 1.799805 | 150 | 7.509766 | null | null | null | null | 0 | <2 mo. follow-up | 0 | 7 | 1 |
78.35699 | male | 1 | 4 | Coma | Coma | 0 | null | under $11k | 0 | 29,703.188 | 19,801.1094 | null | 49 | white | 44.898438 | 73 | 0.049995 | 0.025997 | 1 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 4 | 63 | 32.59375 | 110 | 14 | 39.09375 | 110 | 2 | 10 | 5.199219 | 127 | 7.349609 | null | null | null | null | 0 | <2 mo. follow-up | 0 | 4 | 1 |
59.13797 | female | 1 | 5 | Coma | Coma | 1 | 11 | under $11k | 61 | 10,753.492 | 7,511.3359 | null | 17 | black | 21.296875 | 33 | 0.516968 | 0.445984 | 2 | 0 | 0 | no | 0.01 | 0.000001 | dnr after sadm | 2 | 110 | 18.699219 | 72 | 32 | 38.19531 | 225 | null | null | 1.5 | 163 | 7.469727 | null | null | null | null | 2 | <2 mo. follow-up | 2 | 5 | 1 |
64.98596 | male | 0 | 11 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 32,710.891 | 19,770.6406 | null | 23.5 | white | 23.296875 | 27 | 0.822998 | 0.711914 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 11 | 53 | 6.599609 | 50 | 22 | 36.39844 | null | null | null | 1.399902 | 135 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 | 1,118 | 1 |
90.75397 | female | 0 | 5 | CHF | COPD/CHF/Cirrhosis | 2 | 7 | under $11k | 0 | 2,153.648 | 1,880.4893 | null | 12 | black | 23.199219 | 34 | 0.710938 | 0.55188 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 115 | 1.699951 | 76 | 18 | 34.89844 | null | 2.699707 | 0.299988 | 0.799927 | 146 | null | null | null | null | 4 | 2 | no(M2 and SIP pres) | 2 | 211 | 1 |
69.48895 | female | 0 | 70 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 5 | $11-$25k | 0 | 114,818.812 | 70,177.6875 | null | 21.25 | white | 32.398438 | 43 | 0.525879 | 0.41095 | 17 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 70 | 117 | 10.298828 | 135 | 40 | 38.59375 | 118.32812 | null | null | 0.599976 | 132 | 7.459961 | null | null | null | null | 4 | adl>=4 (>=5 if sur) | 4 | 1,999 | 0 |
71.29095 | female | 0 | 90 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 9 | under $11k | 0 | 117,566.938 | 84,900.625 | null | 24.5 | black | 34.796875 | 69 | 0.475952 | 0.357971 | 1 | 1 | 0 | yes | 0.5 | 0.5 | no dnr | 90 | 55 | 42.898438 | 59 | 8 | 36 | 276.625 | 2.299805 | 6.5 | 5.699219 | 134 | 7.379883 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 | 105 | 1 |
69.30597 | female | 0 | 10 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 12,514.547 | 9,179.7188 | null | 12 | white | 17.898438 | 24 | 0.870972 | 0.786987 | 1 | 0 | 0 | no | 0.9 | 0.6 | no dnr | 10 | 84 | 7.199219 | 96 | 30 | 37 | 385.6875 | null | null | 1.5 | 139 | 7.479492 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 | 58 | 1 |
44.31998 | female | 0 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 9 | 34,999.438 | 24,712.7969 | null | 25.666656 | black | 28.097656 | 36 | 0.795898 | 0.728882 | 1 | 1 | 0 | no | 0.8 | 0.8 | no dnr | 14 | 87 | 12.199219 | 120 | 25 | 38.59375 | 125.45312 | 2.399902 | 1.699951 | 0.799927 | 140 | 7.489258 | null | null | null | null | null | no(M2 and SIP pres) | 2.176758 | 1,997 | 0 |
33.85098 | male | 0 | 22 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 36,510.125 | 26,459.3594 | null | 17 | white | 16.597656 | 11 | 0.819946 | 0.759888 | 4 | 0 | 0 | yes | 0.9 | 0.7 | no dnr | 22 | 79 | 7.699219 | 60 | 10 | 36.29688 | 284.4375 | null | 0.599976 | 1 | 151 | 7.459961 | null | null | null | null | null | null | 1.698242 | 152 | 1 |
51.67697 | male | 0 | 4 | Colon Cancer | Cancer | 1 | 16 | >$50k | 0 | 5,212.348 | 3,679.1934 | null | 9 | white | 21.199219 | 12 | 0.782959 | 0.544922 | 1 | 0 | 0 | metastatic | 0.75 | 0.25 | no dnr | 4 | 63 | 4 | 68 | 18 | 37.39844 | null | 3 | 0.899902 | 0.599976 | 144 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 | 1,995 | 0 |
82.086 | female | 1 | 21 | Coma | Coma | 1 | 10 | under $11k | 100 | 13,969.148 | 11,240.9141 | null | 6 | black | 14.298828 | 22 | 0.310974 | 0.23999 | 1 | 1 | 0 | no | 0 | 0 | dnr after sadm | 1 | 103 | 7.099609 | 80 | 16 | 36.79688 | 263.25 | null | null | 1.299805 | 144 | 7.379883 | null | null | null | null | 5 | <2 mo. follow-up | 5 | 21 | 1 |
40.05197 | female | 0 | 4 | CHF | COPD/CHF/Cirrhosis | 4 | 17 | under $11k | 0 | 10,388.547 | 7,787.3867 | null | 10 | other | 21 | 21 | 0.887939 | 0.812988 | 7 | 1 | 0 | no | 0.9 | 0.7 | no dnr | 4 | 80 | 11.599609 | 88 | 16 | 37 | null | null | null | 1.799805 | 130 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 | 116 | 1 |
43.129 | female | 0 | 15 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 0 | 32,229.891 | 23,546.1875 | null | 25.666656 | white | 19.5 | 13 | 0.906982 | 0.873901 | 1 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 15 | 80 | 12.898438 | 110 | 8 | 36.89844 | 340 | null | 0.699951 | 1.199951 | 142 | 7.479492 | null | null | null | null | 3 | no(M2 and SIP pres) | 3 | 1,994 | 0 |
69.35498 | female | 0 | 12 | CHF | COPD/CHF/Cirrhosis | 3 | 9 | $11-$25k | 0 | 34,208.688 | 20,752.0156 | null | 19 | white | 14.5 | 25 | 0.899902 | 0.832886 | 1 | 1 | 0 | no | 0.98 | 0.9 | no dnr | 12 | 97 | 6.5 | 60 | 28 | 36.79688 | null | 3.799805 | 0.599976 | 1.099854 | 136 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 | 1,994 | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.